Search This Blog

Monday, October 24, 2022

AXDX stock falls as FDA halts marketing of Accelerate Arc

 

Health equipment maker Accelerate Diagnostics, Inc. (NASDAQ:AXDX) dropped ~9% pre-market Monday after announcing that the FDA requested the halt.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.